CVS · News · 20260805N
GLP-1 Lilly Partnership
CVS HEALTH Corp · 2026-08-05 · Importance 31 · Surprise 42 · In source text
CVS Health expanded its direct-to-consumer weight-management program through a collaboration with Eli Lilly and Company. Eligible patients seeking Lilly’s Zepbound and Foundayo can access transparent pricing through the CVS Health app, with same-day pickup planned at approximately 9,000 CVS Pharmacy locations by early Q4 2026. CVS also reduced MinuteClinic digital weight-loss visits to $29 and will combine virtual clinician visits with pharmacist support. The initiative positions CVS across insurance, cash-pay, telehealth and retail-pharmacy channels in the growing GLP-1 market.
Key facts
- New collaboration with Eli Lilly and Company will provide eligible Zepbound and Foundayo patients an additional access point at CVS Pharmacy through the CVS Health app. source
- CVS and Lilly plan transparent pricing in the CVS Health app and potential same-day pickup at approximately 9,000 CVS Pharmacy locations by early Q4 2026. source
- CVS said the Lilly partnership will provide an additional access point for eligible Zepbound and Foundayo patients through MinuteClinic digital visits that combine virtual visits with same-day pharmacy pickup and pharmacist support with no membership or recurring fee. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | New collaboration with Eli Lilly and Company will provide eligible Zepbound and Foundayo patients an additional access point at CVS… |
| revenue | positive | probable | — | CVS and Lilly plan transparent pricing in the CVS Health app and potential same-day pickup at approximately 9,000 CVS Pharmacy locations… |